Yuanfei Zhu

Fudan University — China

Medicine · Health Sciences

18h-index1.8kcitations41works3.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(20), Hepatitis B Virus Studies(11), COVID-19 Clinical Research Studies(7), Hepatitis C virus research(6), Retinal Development and Disorders(5)

Publications41 total

Femtosecond laser-assisted lens exchange with trifocal intraocular lens in a patient with albinism and nystagmus
International Journal of Surgery Case Reports·2025Open Access
Manganese is a potent inducer of lysosomal activity that inhibits de novo HBV infection
PLoS Pathogens·2025· 4 citedOpen Access
Development of a Cell Culture Model for Inducible SARS-CoV-2 Replication
Viruses·2024· 2 citedOpen Access
Hepatitis B virus core protein as a Rab-GAP suppressor driving liver disease progression
Science Bulletin·2024· 11 citedOpen Access
Construction and efficacy testing of DNA vaccines containing HLA-A*02:01-restricted SARS-CoV-2 T-cell epitopes predicted by immunoinformatics
Acta Biochimica et Biophysica Sinica·2024· 1 citedOpen Access
Non-proteolytic ubiquitination of HBx controls HBV replication
Virologica Sinica·2024· 3 citedOpen Access
Humanized mouse lung can be infected by SARS-CoV-2
2023
Canocapavir Is a Novel Capsid Assembly Modulator Inducing a Conformational Change of the Linker Region of HBV Core Protein
Viruses·2023· 12 citedOpen Access
A Spike-destructing human antibody effectively neutralizes Omicron-included SARS-CoV-2 variants with therapeutic efficacy
PLoS Pathogens·2023· 11 citedOpen Access
Neutralization mechanism of a human antibody with pan-coronavirus reactivity including SARS-CoV-2
Nature Microbiology·2022· 145 citedOpen Access
Author Correction: Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2
Cell Research·2022· 6 citedOpen Access
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
Cell·2022· 173 citedOpen Access
Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody
2021· 11 citedOpen Access
Mapping cross-variant neutralizing sites on the SARS-CoV-2 spike protein
Emerging Microbes & Infections·2021· 29 citedOpen Access
Receptome profiling identifies KREMEN1 and ASGR1 as alternative functional receptors of SARS-CoV-2
Cell Research·2021· 163 citedOpen Access
HBV covalently closed circular DNA minichromosomes in distinct epigenetic transcriptional states differ in their vulnerability to damage
Hepatology·2021· 31 cited
A non-ACE2 competing human single-domain antibody confers broad neutralization against SARS-CoV-2 and circulating variants
Signal Transduction and Targeted Therapy·2021· 39 citedOpen Access
Multiomics interrogation into HBV (Hepatitis B virus)-host interaction reveals novel coding potential in human genome, and identifies canonical and non-canonical proteins as host restriction factors against HBV
Cell Discovery·2021· 21 citedOpen Access
Development of recombinant COVID-19 vaccine based on CHO-produced, prefusion spike trimer and alum/CpG adjuvants
Vaccine·2021· 32 citedOpen Access
Novel neutralization mechanism of a human antibody with pan-coronavirus reactivity
Research Square (Research Square)·2021· 1 citedOpen Access
page 1 of 3Next →

Frequent Co-authors

Qiang Deng(23), Youhua Xie(22), Gaowei Hu(12), Rong Zhang(8), Shujuan Du(8), Chenjian Gu(8), Zhenghong Yuan(7), Yuyan Wang(7), Xia Cai(6), Jianqing Xu(5), Yu Zhou(5), Zhong Huang(5), Jing Liu(5), Bogale Aredo(5), Rafael Ufret-Vincenty(5), Yunkai Zhu(4), Zhiping Sun(4), Di Qu(4), Qiang Ding(4), Lu Lu(4)